tiprankstipranks
Pear Therapeutics (PEAR)
NASDAQ:PEAR
US Market

Pear Therapeutics (PEAR) Cash flow

0 Followers

Pear Therapeutics Cash Flow

PEAR's free cash flow for Q was $-25.35M. For the fiscal year, PEAR's free cash flow was decreased by $-3.69M and operating cash flow was $-24.28M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -113.89M$ -113.89M$ -109.04M$ -67.89M$ -36.60M
Investing Cash Flow
$ -9.46M$ -9.46M$ 2.88M$ 58.92M$ -40.56M
Financing Cash Flow
$ 2.15M$ 2.15M$ 164.08M$ 91.70M$ 12.66M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 259.46M$ 48.78M$ 169.98M$ 112.06M$ 29.33M
Income Tax Paid Supplemental Data
-----
Interest Paid Supplemental Data
$ 3.56M$ 3.56M$ 3.71M$ 2.04M$ 260.00K
Issuance Of Capital Stock
-$ 0.00$ 19.92M$ 111.05M$ 50.00K
Issuance Of Debt
--$ 0.00$ 31.00M$ 12.51M
Repayment Of Debt
-$ 0.00$ -1.00M$ -17.28M$ 0.00
Free Cash Flow
$ -117.36M$ -117.36M$ -113.67M$ -71.79M$ -36.88M
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

Pear Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis